Create New Account Purchaser Login
Search Tenders
Search
Advanced Search
You are not logged in.

Future Procurement Opportunity (FPO) – Supply of budesonide/eformoterol dry powder inhalers (DPIs)

Details

RFx ID : 24479707
Tender Name : Future Procurement Opportunity (FPO) – Supply of budesonide/eformoterol dry powder inhalers (DPIs)
Reference # : A1504861
Open Date : Q2 2021
Indicative RFx Release Date  : Q4 2021  [?]
Tender Type : Future Procurement Opportunity (FPO)
Project Status : Initial development  [?]
Indicative Total Value : $50M - $100M  [?]
Expected number of contracts offered : 1
Tender Coverage : Sole Agency  [?]
Categories :
  • 51000000 - Drugs and Pharmaceutical Products
Regions:
  • New Zealand
Required Pre-qualifications : None
Contact : PHARMAC Procurement Team
procurement@Pharmac.govt.nz
Overview

PHARMAC is planning on issuing a competitive process for supply of budesonide/eformoterol dry powder inhalers (DPIs).

The approximate annual gross expenditure of budesonide/eformoterol DPIs in the 2020 FYR was $25,000,000. For current funding information please view the Pharmaceutical Schedule: https://www.pharmac.govt.nz/tools-resources/pharmaceutical-schedule/community/